Phase 2 Colorectal Cancer Trial, Recruiting (NCT06493760)

Phase 2 Colorectal Cancer Trial, Recruiting NCT06493760 Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. Condition: Colorectal Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06493760 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Colorectal Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years of age or older (male or female)
You have been diagnosed with colorectal cancer that has spread to other parts of the body, confirmed by a lab test on a tissue or cell sample
You are generally able to carry out daily activities with little to no limitation (confirm with trial site)
You are expected to live for at least 12 weeks or more
You are willing and able to sign a consent form agreeing to take part in the trial

Who may not be able to join:

You have cancer that has spread to the brain or spinal cord and is not well controlled or is causing symptoms
You are still experiencing significant side effects (other than hair loss or tiredness) from a previous cancer treatment
Your organs (such as liver or kidneys) or bone marrow are not functioning well enough (confirm with trial site)
You are currently pregnant or breastfeeding
You have a known allergy or sensitivity to the study drug SSGJ-707

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06493760

Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Phase: Phase 2

Status: Recruiting

Condition: Colorectal Cancer

More information: https://clinicaltrials.gov/study/NCT06493760

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years of age or older (male or female)
You have been diagnosed with colorectal cancer that has spread to other parts of the body, confirmed by a lab test on a tissue or cell sample
You are generally able to carry out daily activities with little to no limitation (confirm with trial site)
You are expected to live for at least 12 weeks or more
You are willing and able to sign a consent form agreeing to take part in the trial

Who may not be able to join:

You have cancer that has spread to the brain or spinal cord and is not well controlled or is causing symptoms
You are still experiencing significant side effects (other than hair loss or tiredness) from a previous cancer treatment
Your organs (such as liver or kidneys) or bone marrow are not functioning well enough (confirm with trial site)
You are currently pregnant or breastfeeding
You have a known allergy or sensitivity to the study drug SSGJ-707

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Registry

ClinicalTrials.gov

Start date

3 September 2024

Est. completion

1 June 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

ORR; Safety and tolerability

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov